Articles liés à From Traditional Pharma to Intelligent Enterprise:...
From Traditional Pharma to Intelligent Enterprise: How CEOs Transform Manufacturing with AI without Breaking GMP - Couverture souple
Livre 3 sur 5: Pharma?s AI Transformation
Synopsis
How CEOs and Quality Leaders Navigate AI, GMP, and Complexity Without Losing Control
Pharma is not failing at digital transformation. It is failing at thinking about complexity.
Despite massive investment in AI, automation, and digital initiatives, most pharmaceutical organizations feel heavier, slower, and more fragile than ever. Quality systems are overloaded. Experts are exhausted. Leaders carry increasing risk with diminishing visibility.
This book explains why and what to do instead.
Written for CEOs, board members, senior quality leaders, and manufacturing executives, this is not a technology book. It is a leadership and system-intelligence guide for regulated environments where mistakes are not an option.
Inside, you’ll discover:
- Why most AI and digital programs stall or quietly increase risk
- How GMP authority can remain fully human while intelligence scales safely
- Why documentation, not equipment, is the highest ROI transformation lever
- How quality becomes lighter, not weaker, when intelligence is introduced correctly
- What regulators actually care about (and what they don’t)
- Why intelligence, not size, will determine which pharma companies survive
It does not sell tools, vendors, or frameworks. It offers something far rarer: clarity.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Résultats de recherche pour From Traditional Pharma to Intelligent Enterprise:...
Image d'archives
From Traditional Pharma to Intelligent Enterprise (Paperback)
impression à la demandeVendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Paperback. Etat : new. Paperback. How CEOs and Quality Leaders Navigate AI, GMP, and Complexity Without Losing ControlPharma is not failing at digital transformation. It is failing at thinking about complexity.Despite massive investment in AI, automation, and digital initiatives, most pharmaceutical organizations feel heavier, slower, and more fragile than ever. Quality systems are overloaded. Experts are exhausted. Leaders carry increasing risk with diminishing visibility.This book explains why and what to do instead.Written for CEOs, board members, senior quality leaders, and manufacturing executives, this is not a technology book. It is a leadership and system-intelligence guide for regulated environments where mistakes are not an option.Inside, you'll discover: Why most AI and digital programs stall or quietly increase riskHow GMP authority can remain fully human while intelligence scales safelyWhy documentation, not equipment, is the highest ROI transformation leverHow quality becomes lighter, not weaker, when intelligence is introduced correctlyWhat regulators actually care about (and what they don't)Why intelligence, not size, will determine which pharma companies surviveThis book does not promote automation of decisions. It does not advocate regulatory shortcuts.It does not sell tools, vendors, or frameworks. It offers something far rarer: clarity. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9798246742549
Acheter neuf
EUR 14,65
Livraison gratuite
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : 1 disponible(s)
Image d'archives
From Traditional Pharma to Intelligent Enterprise: How CEOs Transform Manufacturing with AI without Breaking GMP (Pharma's AI Transformation)
impression à la demandeVendeur : California Books, Miami, FL, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. Print on Demand. N° de réf. du vendeur I-9798246742549
Acheter neuf
EUR 14,66
Livraison gratuite
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image d'archives
From Traditional Pharma to Intelligent Enterprise
impression à la demandeVendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
PAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9798246742549
Acheter neuf
EUR 14,73
Livraison gratuite
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image d'archives
From Traditional Pharma to Intelligent Enterprise
impression à la demandeVendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9798246742549
Acheter neuf
EUR 13,14
Expédition à EUR 3,90
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
From Traditional Pharma to Intelligent Enterprise : How CEOs Transform Manufacturing with AI without Breaking GMP
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. Neuware - How CEOs and Quality Leaders Navigate AI, GMP, and Complexity Without Losing ControlPharma is not failing at digital transformation. It is failing at thinking about complexity.Despite massive investment in AI, automation, and digital initiatives, most pharmaceutical organizations feel heavier, slower, and more fragile than ever. Quality systems are overloaded. Experts are exhausted. Leaders carry increasing risk with diminishing visibility.This book explains why and what to do instead.Written for CEOs, board members, senior quality leaders, and manufacturing executives, this is not a technology book. It is a leadership and system-intelligence guide for regulated environments where mistakes are not an option.Inside, you'll discover: - Why most AI and digital programs stall or quietly increase risk- How GMP authority can remain fully human while intelligence scales safely- Why documentation, not equipment, is the highest ROI transformation lever- How quality becomes lighter, not weaker, when intelligence is introduced correctly- What regulators actually care about (and what they don't)- Why intelligence, not size, will determine which pharma companies surviveThis book does not promote automation of decisions. It does not advocate regulatory shortcuts.It does not sell tools, vendors, or frameworks. It offers something far rarer: clarity. N° de réf. du vendeur 9798246742549
Acheter neuf
EUR 24,38
Expédition à EUR 35
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 2 disponible(s)
Image d'archives
From Traditional Pharma to Intelligent Enterprise (Paperback)
impression à la demandeVendeur : CitiRetail, Stevenage, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Paperback. Etat : new. Paperback. How CEOs and Quality Leaders Navigate AI, GMP, and Complexity Without Losing ControlPharma is not failing at digital transformation. It is failing at thinking about complexity.Despite massive investment in AI, automation, and digital initiatives, most pharmaceutical organizations feel heavier, slower, and more fragile than ever. Quality systems are overloaded. Experts are exhausted. Leaders carry increasing risk with diminishing visibility.This book explains why and what to do instead.Written for CEOs, board members, senior quality leaders, and manufacturing executives, this is not a technology book. It is a leadership and system-intelligence guide for regulated environments where mistakes are not an option.Inside, you'll discover: Why most AI and digital programs stall or quietly increase riskHow GMP authority can remain fully human while intelligence scales safelyWhy documentation, not equipment, is the highest ROI transformation leverHow quality becomes lighter, not weaker, when intelligence is introduced correctlyWhat regulators actually care about (and what they don't)Why intelligence, not size, will determine which pharma companies surviveThis book does not promote automation of decisions. It does not advocate regulatory shortcuts.It does not sell tools, vendors, or frameworks. It offers something far rarer: clarity. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9798246742549
Acheter neuf
EUR 17,09
Expédition à EUR 43,88
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : 1 disponible(s)